Treatment of climacteric symptoms in Finland prior to the controversial reports on hormone therapy

Acta Obstetricia et Gynecologica Scandinavica

Volumn 87, Issue 6, 2008, Pages 682-686

  Jalava Broman, Jaana ^a,b   Mäkinen, Juha ^a   Ojanlatva, Ansa ^a,c   Jokinen, Kirsi ^d   Sillanmäki, Lauri ^a,e   Rautava, Päivi ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b Health Care Unit   (Finland)

^c TURKU CITY HOSPITAL   (Finland)

^d University of Helsinki ^*  (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Climacteric; Hormone therapy; Menopause; Middle aged women

Indexed keywords

ANTIDEPRESSANT AGENT; ESTROGEN; HYPNOTIC AGENT; LEVONORGESTREL; PROGESTERONE; TESTOSTERONE; TIBOLONE; TRACE ELEMENT; TRANQUILIZER; VITAMIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST CANCER; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; FINLAND; HORMONAL THERAPY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVARIECTOMY; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL ASPECT; UNIVARIATE ANALYSIS; VOCATIONAL EDUCATION;

ADULT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; QUALITY OF LIFE;

EID: 45949112424     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340802146920     Document Type: Article

References (27)

1. Oldenhave A, Jaszmann L, Haspels A, Everaerd W. Impact of climacteric on well-being. Am J Obstet Gynecol. 1993;168:772-80.
2. Jokinen K, Rautava P, Mäkinen J, Ojanlatva A, Sundell J, Helenius H. Experience of climacteric symptoms among 42-46 and 52-56-year-old women. Maturitas. 2003;46:199-205.
3. Stearns V, Ullmer L, Lopez JF, Smith J, Isaacs Y, Hayes D. Hot flushes. Lancet. 2002;360:1851-61.
4. Notelovitz M, Cassel D, Hille D, Furst KW, Dain M-P, VandePol C, et al. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause. Am J Obstet Gynecol. 2000;182:7-12.
5. Mac Lennan A, Lester S, Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: a systemic review. Climacteric. 2001;4:58-74.
6. Barnabei VM, Grady D, Stovall DW, Cauley JA, Lin F, Stuenkel CA, et al. Menopausal symptoms in older woman and the effects of treatment with hormone therapy. Obstet Gynecol. 2002;100:1209-18.
7. Mäntyranta T, Hemminki E, Kangas I, Topo P, Uutela A. Alternative drugs use for the climacteric in Finland. Maturitas. 1997;27:5-11.
8. Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol. 1990;163:1438-44.
9. Egeland GM, Matthews KA, Kuller LH, Kelsey SF. Characteristics of no contraceptive hormone users. Prev Med. 1988;17:403-11.
10. Ghali WA, Freund KM, Boss RD, Ryan CA, Moskowitz MA. Menopausal hormone therapy: physician awareness of patient attitudes. Am J Med. 1997;103:3-10.
11. Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in United States. Ann Intern Med. 1999;130:545-53.
12. The Writing Group for the PEPI trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA. 1995;273:199-208.
13. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000;133:933-41.
14. Hirvonen E. Vaihdevuosien hormonikorvaushoito Suomessa [Climacteric hormone therapy in Finland]. Suom. Lääkärilehti. 1997;52:1669-72.
15. Martikainen J. Vaihdevuosien hormonihoito Suomessa [Climacteric hormone therapy in Finland in 1997]. Kapseli. 1998;28:34-6.
16. Korkeila K, Suominen S, Ahvenainen J, Ojanlatva A, Rautava P, Helenius H, et al. Non-response and related factors in a nationwide health survey. Eur J Epidemiol. 2001;17:991-9.
17. Stadberg E, Mattsson L-Å, Milsom I. Factors associated with climacteric symptoms and the use of hormone replacement therapy. Acta Obstet Gynecol Scand. 2000;79:282-92.
18. Kupperman HS, Blatt MH, Wiesbader H, Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. Endocrinology. 1953;13:688-703.
19. Topo P, Køster A, Holte A, Collins A, Langgren B-M, Hemminki E, et al. Trends in the use of climacteric and postclimacteric hormones in Nordic countries. Maturitas. 1995;22:89-95.
20. Rödström K, Bengtsson C, Lissner L, Milsom I, Sundh V, Björkelund C. A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarte of a century. Menopause. 2002;9:156-61.
21. Kuh D, Hardy R, Wadsworth M. Social and behavioural influences on the uptake of hormone replacement therapy among younger women. Br J Obstet Gynaecol. 2000;107:731-9.
22. Ringa V, Ledésert B, Gueguen R, Schiele F, Breart G. Determinants of hormonal replacement therapy in recently postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 1992;45:192-200.
23. Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women's characteristics. J Clin Epidemiol. 1993;46:211-9.
24. Thunell L, Stadberg E, Milsom I, Mattsson L-Å. Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval. Acta Obstet Gynecol Scand. 2005;84:395-401.
25. Collins A, Landgren B-M. Psychosocial factors associated with the use of hormonal replacement therapy in a longitudinal follow-up study of Swedish women. Maturitas. 1997;28:1-9.
26. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Hutchinson F, et al. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-33.
27. Million Woman Study Collaborators. Breast cancer and hormone-replacement therapy in the million women study. Lancet. 2003;362:419-27.